Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

It was recommended that SAG-M be introduced as soon as possible, and it was to be expected that it would yield a considerable increase in plasma which might be available to BPL for fractionation.

Published on: 30 August, 2024

Dr Lane recorded that it was in the last quarter of 1984 that plasma supplies to BPL increased as a result of SAG-M.

Published on: 30 August, 2024

Plasmapheresis first began in the United Kingdom in early 1967.

Published on: 30 August, 2024

The Joint Steering Committee on Blood Products Production thought that the use of plasmapheresis might be difficult to justify as a means to meet targets because it inevitably exposed donors to risk.

Published on: 30 August, 2024

The Central Committee for the National Blood Transfusion Service expressed the view that increased plasma supplies could be achieved either by increasing concentrated red cell use or by plasmapheresis.

Published on: 30 August, 2024

In a meeting between Dr Biggs and Dr Rizza, they explored the Factor 8 market and investigated the reasons for choosing one commercial brand over another.

Published on: 30 August, 2024

A DHSS minute recorded that it was not the intention to embark on a programme of plasmapheresis in England.

Published on: 30 August, 2024

The Scottish National Blood Transfusion Service Annual Report recorded that there was an increase of 82% in the number of units obtained by plasmapheresis of fresh frozen plasma. It seemed that Edinburgh, in particular, was using more plasmapheresis.

Published on: 30 August, 2024

The Code of Practice for the Clinical Use of Blood Cell Separators determined that a cardiac arrest team had to be available when machine plasmapheresis was used due to the risk of cardiac arrest occurring.

Published on: 17 October, 2024

Dr Robinson set up a pilot unit for plasmapheresis in Yorkshire in 1980.

Published on: 30 August, 2024

Dr Gunson stated that plasmapheresis should be addressed further and that centres with a 3-4 million population were ideally suited to that method of plasma collection.

Published on: 30 August, 2024

In Dr Gunson's notes on a visit to the Yorkshire RTC, he commented on the automated machines operating at the Yorkshire RTC spread across three sites, staffing and agreed targets.

Published on: 30 August, 2024

In a visitors note to the North East Thames RTC to discuss plasma supply, it was stated that Dr Harrison did not consider plasmapheresis to be an efficient way to collect plasma.

Published on: 30 August, 2024

In her written statement, Dr Harrison stated that recovered plasma was preferred to manual or machine plasmapheresis as it was much cheaper. It did not involve the cost of plasmapheresis equipment or static centres.

Published on: 17 October, 2024

In the transcript of Dr Lloyd's oral evidence he stated that the Newcastle RTC had a small plasmapheresis unit, but mostly plasma was recovered from whole blood donations.

Published on: 30 August, 2024

In his written statement, Dr Lloyd stated that the Newcastle RTC increased its plasma production for fractionation; the 1992/1993 plasma production figures, based on tonnes of plasma per million population, put the Newcastle Centre third behind the North London and Yorkshire centres.

Published on: 30 August, 2024

In the BPL and PFL Annual Report it was reported that plasmapheresis continued to grow as a source of plasma. In 1986/87 it gave rise to just over 10% of the plasma sent to BPL.

Published on: 30 August, 2024

In a memo from Dr Smith to Dr Lane, the possibility of small pool freeze-dried cryoprecipitate was discussed.

Published on: 30 August, 2024

The Chronological Presentation on the Domestic Supply of Blood Products in England and Wales held that expenditure for 1976/77 was set at £433,000 before cost adjustments, including revenue allocations.

Published on: 11 October, 2024

In a memo, it was noted that the Northern and West Midlands regions had not committed to providing plasma. The Northern region was offered increased capital, and the West Midlands region was offered an increased revenue allocation.

Published on: 30 August, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2127
  • Page 2128
  • Page 2129
  • Page 2130
  • Current page 2131
  • Page 2132
  • Page 2133
  • Page 2134
  • Page 2135
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.